Summary: ORIGINAL CONTRIBUTION
Impact of Annual Targeted Treatment
on Infectious Trachoma and Susceptibility
to Reinfection
Berna Atik, MD, MPH
Ton Ton Kim Thanh, MD
Vu Quoc Luong, MD
Stephane Lagree, PhD
Deborah Dean, MD, MPH
I
N 1995, THE WORLD HEALTH ORGA-
nization(WHO)firstpublisheddata
onglobalblindnessandreportedthat
15% of cases were due to tra-
choma,1
making it the second major
cause of blindness after cataract.1
At that
time, the WHO estimated that 146 mil-
lion individuals were in need of treat-

Source: Arnold, Jonathan - Nanoscale Science and Engineering Center & Department of Genetics, University of Georgia

Collections: Biotechnology